Abstract. We examined the uptake and intracellular transport of the fluorescent glucosylceramide analogue N-[5-(5,7-dimethyl BODIPY'~)-l-pentanoyl] -glucosyl sphingosine (CrDMB-GlcCer) in human skin fibroblasts, and we compared its behavior to that of the corresponding fluorescent analogues of sphingomyelin, galactosylceramide, and lactosylceramide. All four fluorescent analogues were readily transferred from defatted BSA to the plasma membrane during incubation at 4°C. When cells treated with CrDMB-GlcCer were washed, wanned to 370C, and subsequently incubated with defatted BSA to remove fluorescent lipid at the cell surface, strong fluorescence was observed at the Golgi apparatus, as well as weaker labeling at the nuclear envelope and other intracellular membranes. Similar results were obtained with Cs-DMB-galactosylceramide, except that labeling of the Golgi apparatus was weaker than with Cs-DMB-GlcCer. Internalization of Cs-DMB-GlcCer was not inhibited by various treatments, including ATP depletion or wanning to 190C, and biochemical analysis demonstrated that the lipid was not metabolized during its internalization. However, accumulation of Cs-DMB-GlcCer at the Golgi apparatus was reduced when cells were treated with a nonfluorescent analogue of glucosylceramide, suggesting that accumulation of Cs-DMBGlcCer at the Golgi apparatus was a saturable process. In contrast, cells treated with CrDMB-analogues of sphingomyelin or lactosylceramide internalized the fluorescent lipid into a punctate pattern of fluorescence during warming at 37°C, and this process was temperature and energy dependent. These results with CrDMB-sphingomyelin and Cs-DMB-lactosylceramide were analogous to those obtained with another fluorescent analogue of sphingomyelin in which labeling of endocytic vesicles and plasma membrane lipid recycling were documented (Koval, M., and R. E. Pagano. 1990. J. Cell Biol. 111:429--442). Incubation of perforated cells with Cs-DMB-sphingomyelin resulted in prominent labeling of the nuclear envelope and other intracellular membranes, similar to the pattern observed with CrDMB-GIcCer in intact cells. These observations are consistent with the transbilayer movement of fluorescent analogues of glucosylceramide and galactosylceramide at the plasma membrane and early endosomes of human skin fibroblasts, and suggest that both endocytic and nonendocytic pathways are used in the internalization of these lipids from the plasma membrane. Cs-DMB-GaiCer, Cs-DMB-galactosyl sphingosine; Cs-DMB-GlcCer, Cs-DMB-glucosyl sphlngosine; Cs-DMBLa¢Cer, Cs-DMB-lactosyl sphingosine; Cs-DMB-SM, C~-DMB-sphingosylphosphorylcholine; Ct-GalCer, N-hexanoyl-galactosyl sphingosine; Ct-GIcCer, N-hexanoyl-glucosyl sphingosine; amino] hexanoyl])glucosyl sphingosine; Cer, ceramide; GlcCer, glucosylceramide; DF-BSA, defatted BSA; GSL, glycosphingolipid; HMEMB, 10 mM 4-(2-hydroxyethyl)-l-piperazineethane sulfi3aic acid-buffered MEM, pH 7.4, without indicator, and containing 0.5 mM each choline chloride, ethanolamine, serine, and (myo)inositol; LacCer, lactosylceramide; SM, sphingomyelin.
mide, suggesting that accumulation of Cs-DMBGlcCer at the Golgi apparatus was a saturable process. In contrast, cells treated with CrDMB-analogues of sphingomyelin or lactosylceramide internalized the fluorescent lipid into a punctate pattern of fluorescence during warming at 37°C, and this process was temperature and energy dependent. These results with CrDMB-sphingomyelin and Cs-DMB-lactosylceramide were analogous to those obtained with another fluorescent analogue of sphingomyelin in which labeling of endocytic vesicles and plasma membrane lipid recycling were documented (Koval, M., and R. E. Pagano. 1990. J. Cell Biol. 111:429--442) . Incubation of perforated cells with Cs-DMB-sphingomyelin resulted in prominent labeling of the nuclear envelope and other intracellular membranes, similar to the pattern observed with CrDMB-GIcCer in intact cells. These observations are consistent with the transbilayer movement of fluorescent analogues of glucosylceramide and galactosylceramide at the plasma membrane and early endosomes of human skin fibroblasts, and suggest that both endocytic and nonendocytic pathways are used in the internalization of these lipids from the plasma membrane.
LYCOSPHINGOLIPIDS (GSLs) ~ are constituents of the plasma membranes of all eukaryotic cells and play important roles in cell-cell interactions, modulation of cell growth and differentiation, and intracellular signaling. The backbone of GSLs is synthesized at the endoplasmic reticulurn and subsequently transported to the Golgi
Lipids
Cs-DMB-sphingosylphospborylcholine (Cs-DMB-SM), Cs-DMB-v-erythro- sphingosine (Cs-DMB-Cer), and Cs-DMB-fatty acid were obtained from Molecular Probes, Inc. (Eugene, OR). C5-DMB-GIcCer, Cs-DMB-GalCer, and Cs-DMB-LacCer were prepared by N-acylation (Schwat'zmann and Sandhoff, 1987) of glucopsychosine, psychosine, and "lyso-LacCer" (a generous girl from Dr. G. Schwatzmann, University of Bonn, Bonn, Germany), respectively, using the N-hydroxysuccinimide ester of the Cs-DMB-fatty acid. Nonfluorescent, short-chain analogues of glucosylceramide (GlcCer) and galactosylceramide (GalCer) were prepared in a similar manner using the N-bydroxysuccinimidyl esters of acetic acid and bexanoic acid. The sphingolipids were purified by preparative thin-layer chromatography using CHC13/MeOH/15 mM CaCh (60:35:8, vol/vol/vol) as the developing solvent. The concentration of the Cs-DMB-SM stock solution was determined by phosphorus analysis (l~user et al., 1981) . The concentrations of Cs-DMB-GIcCer, Cs-DMB-GalCer, Cs-DMB-LacCcr, and Cs-DMB-Cer stock solutions were determined by measuren~nt of their fluorescence intensities relative to Cs-DMB-SM, using CHCI3/MeOH (2:1, vol/vol) as the solvent. (The ratio of fluorescence to absorbance at 508 nm was the same for all five lipids.) Fluorescence measurements were per~rmed using an SLM 8000C spectrophotofluorimoter (SLM Instruments, Inc., Urbana, IL) (~ = 480 nm; ~rn = 516 nm).
Sphingolipid/BSA Complexes
Complexes of Cs-DMB-Cer, Cs-DMB-GlcCer, Cs-DMB-C.mlCer, C5-DMB-LacCer, and Cs-DMB-SM were prepared as described (Pageno and Martin, 1988) , except that the complexes contained 25/~M each of fluorescent lipid and BSA. Briefly, 250 nmol of the desired Cs-DMB-lipid in a CHCIs/MeOH stock solution was dried, first under a stream of nitrogen and then in vacuo. The dried lipid was dissolved in 200 #1 of ethanol and injected into 10 ml of HMEMB containing 1.7 mg defatted BSA (DF-BSA)/ml while being vortex mixed. The complex was dialyzed overnight at 4°C against 500 ml of 10 mM 4-(2-hydroxyethyl)-l-piperazineethane sulfoulc acid-buffered MEM, pH 7.4, without indicator and containin$ 0.5 mM each choline, chloride, ethanolamine, serine, and (myo)inositol (HMEMB) and then frozen at -20°C in plastic tubes. Before use, the complexes were diluted with HMEMB as required. Complexes of N-acetylglucosyl sphingosine (C2-GlcCer) or N-acetyl-gelactosyl sphingosine (C2-GalCer) and N-hexanoyl-glucosyl sphingosine (Ct-GIcCer) or N-hexanoylgalactosyl sphingosine (Ct-OalCer) were prepared in a similar manner, except that the ratio of lipid to BSA was 2:1 (mol/mol).
Incubaffon of Fluorescent Lipids with Cells
Cultures were washed in HMEMB, incubated with 2.5, 5, or 10/~M (as indieated) Cs-DMB-sphingolipid/DtLBSA in HMEMB for 30 min at 2°C, washed, and further incubated in HMEMB for 0-30 rain at 37°C. In some experiments, the cultures were chilled and incubated at II°C (six times, 10 min each) with HMEMB containing 2 % DF-BSA ("back exchange") or with HMEMB alone before photography or biochomicni analysis.
In biochemical experiments, cells were harvested after the appropriate incubation using a rubber policeman, washed by centrifugetion, resuspended, and aliquots were removed for protein content determination (Lowry et al., 1951) and for lipid extraction 08ligh and Dyer, 1959). The relative fluorescence of the lipid extracts was determined (k~ ffi 495 nm; Figure 1 . Redistribution of Cs-DMB-GIcCer from the plasma membrane to intracellular membranes with time at 37°C. Cells were incubated with Cs-DMB-GIcCer/BSA complex for 30 rain at 2°C, washed, warmed for (A) 0, (B) 5, (C) 15, or (D) 30 min at 37°C, and subsequently "back exchanged" (see Materials and Methods). Separate photomicrographs of a given field were obtained at green + red wavelengths (/eft panels, 3520 nm) and red wavelengths (right pane/s, 3590 nm). Note the redistribution of fluorescence to numerous intracellular membranes including the Golgi apparatus in (C) and (D). Bar, 10/~m. hem = 515 nm) and normalized to the protein content. The amounts of fluorescent Cs-DMBqipid present in the cell extracts were determined by standard curves generated from lipid extracts, prepared from various amounts of each Cs-DMB-lipid/BSA complex. Lipid extracts were also analyzed qualitatively by thin-layer chromatography.
Miscellaneous Procedures
For experiments using perforated cells, cells were washed with HMEMB, perforated by filter stripping (Simons and Virta, 1987; Kobayashi and Pagano, 1988) , labeled with 5 ~tM Cs-DMB-lipid/BSA in transport medium (see Gravotta et al., 1990) for 15 rain at 2°C, washed in transport medium, and photographed. Cells were treated with inhibitors as described in the second footnote of Table II .
Control cells or ATP-depleted cells (see Table II , second footnote) were incubated for 30 rain at 37"C with 1 mg/ml Texas red-labeled dextran (10 kD; Molecular Probes, Inc.) in the absence (control) or presence (ATP depleted) of inlfibitors, washed, and observed by fluorescence microscopy.
Fluorescence microscopy was performed with an inverted microscope 0M-35; Carl Zeiss, Inc., Thornwood, NY) equipped with a Planapo 100X (1.3 NA) objective and epithorescence optics. Samples were excited at 450-490 nm, and the fluorescence observed at either ~520 nm (green + red wavelengths) or at ;~590 um (red wavelengths) (see Pagano et al,, 1991) . Photomicrographs representative of observations of large numbers of cells in each sample were obtained either in color using Kodak Ektachrome 400 film (4-s exposure), which was pushed one stop during processing, or black and white using Kodak Tri-X film (4-s exposure) and processed at AS& 1600 with a developer (Dialine; At:urine, Chicago, IL). All micrographs from a given experiment were printed identically.
Results

Uptake and Back Exchangeability of CrDMB-labeled Lipids
We first examined the uptake of Cs-DMB-GlcCer, Cs-DMB-GalCer, and Cs-DMB-SM using equal concentrations of the fluorescent lipid/DF-BSA complexes. Cells were incubated with 5 /zM C5-DMB-lipid/BSA for 30 rain at 20C, washed, and the lipids were extracted and quantified. The amount of cell-associated Cs-DMB-SM and Cs-DMBGalCer were nearly equal, but were considerably greater than the amount of cell-associated Cs-DMB-GIcCer. This difference in uptake was diminished by increasing the concentration of Cs-DMB-GlcCer/BSA to 10 /~M (Table I) . When cells treated under these conditions were examined under the fluorescence microscope, only plasma membrane fluorescence was detected, and the fluorescence emission was orange in each case. Since the fluorescence emission spectrum of C5-DMB-lipids is concentration dependent , these observations suggest that the different CrDMB-lipid species had similar "local" concentrations in the plasma membrane bilayer.
We also examined the ability of each of the C5-DMBlipids to be removed from the plasma membrane by incubation with a nonfluorescent acceptor (back exchange). Both Cs-DMB-GalCer and Cs-DMB-SM were almost completely removed by incubation with DF-BSA, while significantly more of the Cs-DMB-GlcCer taken up by cells at 20C remained cell associated after back exchange. This result was confirmed qualitatively by fluorescence microscopy, in which plasma membrane labeling was readily observed after back exchange of cells treated with Cs-DMB-GlcCer, but was not seen with Cs-DMB-SM or CrDMB-GalCer. Lipid extraction and analysis confirmed that the cell-associated fluorescence was from Cs-DMB-GlcCer, and not from a fluorescent metabolite or breakdown product (data not shown). Fig. 1 shows a time course for redistribution of Cs-DMBfluorescence from the plasma membrane to intracellular membranes. Cells were incubated with Cs-DMB-GlcCer/ BSA for 30 rain at 2°C, washed, warmed to 37°C for various times, back exchanged at 10°C, and observed at either >-520 nm (left panels, green + red wavelengths) or at >-590 nm (right panels, red wavelengths) (see Pagano et al., 1991) .
Time Course for Internalization of CrDMB-GlcCer at 37°C
When cells were observed at >-520 nm, fluorescence was initially seen only at the plasma membrane (Fig. 1 A) . After 5 rain at 37°C the fluorescence was also seen in "dotlike" structures scattered throughout the cytoplasm (Fig. 1 B) . By 15-30 rain of incubation, almost all of the cell-associated fluorescence was seen at the Golgi apparatus, nuclear envelope, and other intracellular membranes (Fig. 1, C and D) . When the same cells were observed at red wavelengths so that only membranes containing high concentrations of the CrDMB-lipids were seen (see Pagano et al., 1991) , redistribution of fluorescence from the plasma membrane to endosomes, and later to the Golgi apparatus, was seen ( Fig. 1, right panels). However, no labeling of the ER or plasma membrane was detected in the red microscope channel, suggesting that the concentration of the Cs-DMB-lipids in these membranes was relatively low.
We next compared the uptake and distribution of Cs-DMBGlcCer, Cs-DMB-GalCer, Cs-DMB-SM, and Cs-DMBLacCer in human skin fibroblasts (Fig. 2 ). Cells were incubated with these lipids for 30 rain at 2°C, washed, wanned to 37°C for 15 rnin, back exchanged, and then observed under the fluorescence microscope at green + red wavelengths. CrDMB-SM was distributed in a punctate pattern throughout the cytoplasm (Fig. 2 A) , and, by analogy to previous studies using another fluorescent analogue of sphingomyelin (K_oval and Pagano, 1990) , labeled the endosomes and Golgi apparatus. CrDMB-LacCer gave a similar labeling pattern to that seen with C5-DMB-SM (Fig. 2 B) . In contrast, treatment with Cs-DMB-GlcCer resulted in strong labeling of the Golgi apparatus, as well as weaker labeling of the plasma membrane, nuclear envelope, and other intracellular membranes (Fig. 2 C) . Some weak labeling of endosomes was also observed. Interestingly, cells treated with Cs-DMB-GalCer exhibited labeling of both vesicle-like structures, as well as numerous other intracellular membranes, including the Golgi apparatus (Fig. 2 D) . However, labeling of the Golgi apparatus was considerably weaker than when CrDMB-GlcCer was used (compare Fig. 2, C vs D) .
Lipid extraction and analysis of cells that were treated with C5-DMB-GlcCer/BSA for 30 rain at 2°C, washed, and warmed for 30 rain at 37°C showed that >-98 % of the cellassociated fluorescence was from Cs-DMB-GlcCer (data not shown). In addition, when Cs-DMB-GIcCer/BSA was incubated with mutant (Gaucher's) fibroblasts lacking glucocerebrosidase (Brady et al., 1965) , an identical pattern of labeling to that seen in normal fibroblasts was observed, demonstrating that the intracellular fluorescence seen with Cs-DMB-GlcCer was not caused by its hydrolysis.
Finally, we note that when cells treated with BSA complexes of Cs-DMB-GaICer, Cs-DMB-LacCer, or Cs-DMB-SM were observed at >-520 nm (green + red wavelengths), an interesting pattern of fluorescence labeling of the endosomes was seen. Namely, within the same cell, some endo- 
Distribution of CrDMB-lipids in Perforated Cells
We next examined the intracellular distribution of Cs-DMB-SM in intact vs perforated cells. Cs-DMB-SM labeled the plasma membrane of intact cells at low temperature (Fig. 3 A) and distributed into endocytic vesicles upon warming the cells to 37°C (Fig. 2 A) . However, when cells were perforated before (Fig. 3 B) or after (data not shown) incubation with the fluorescent lipid at low temperature, numerous intracellular membranes, including the ER, mitochondria, and nuclear envelope, were labeled. Similar experiments were performed at low temperature using Cs-DMB-GIcCer and Cs-DMB-GalCer, and, in both cases (data not shown), the fluorescent lipids labeled the plasma membrane of intact cells and the intracellular membranes of perforated cells. These results demonstrate that labeling of intracellular membranes by Cs-DMB-llpids can occur once the lipids cross the plasma membrane bilayer. Indeed, both intact and perforated cells incubated with Cs-DMB-Cer gave identical patterns of intracellular labeling (data not shown), presumably because ceramide analogues undergo spontaneous transbilayer movement (Pagano and Martin, 1988; Pagano, 1989) and readily cross the plasma membrane bflayer of intact cells.
Effects of ATP Depletion and Temperature on the Intraceilular Distribution of C,-DMB-GIcCer
The effect of ATP depletion on the internalization of Cs-DMB-SM (Fig. 4) and Cs-DMB-GlcCer (Fig. 5) was examined. Control or ATP-depleted cells were incubated with the fluorescent lipid for 30 rain at 2°C, washed, warmed to 37°C for 30 rain, back exchanged with DF-BSA, and observed at either/>520 nm (/eft panels, green + red wavelengths) or at />590 nm (right panels, red wavelengths). All steps were performed in the absence or presence of inhibitors. When CrDMB-SM was used, punctate labeling corresponding to labeled endosomes was readily seen in control cells (Fig. 4 A), but intracellular labeling was inhibited in ATP-depleted ceils (Fig. 4 B) . These ATP-depletion conditions also inhibited the internalization of Texas red dextran (see Materials and Methods), a fluid phase endocytic marker (Koval and Pagano, 1990 ) (data not shown). In contrast, when Cs-DMB-GIcCer (Fig. 5) or Cs-DMB-GalCer were used (data not shown), punctate labeling was inhibited by ATP depletion (compare Fig. 5 , B vs A), but labeling of the endoplasmic reticulum, mitochondria, and nuclear envelope were not affected. As in control cells (see above),/>98 % of the cellassociated fluorescence in lipid extracts of ATP-depleted cells was from Cs-DMB-GlcCer (data not shown). Interestingly, ATP depletion appeared to reduce the accumulation of Cs-DMB-GlcCer at the Golgi apparatus (Fig. 5 B, 
right panel).
We also examined the effect of temperature on CrDMBGlcCer internalization (Fig. 6 ). Cells were incubated with Cs-DMB-GlcCer for 30 min at 2°C, washed, and warmed to 10°C (2 h), 19°C (2 h), or 37°C (15 min) before back exchange with DF-BSA. While treatment of cells at 10°C inhibited internalization (Fig. 6 A) , labeling of intracellular membranes was readily seen at 19°C (Fig. 6 B) , as well as 37°C (Fig. 6 C) .
Evaluation of Potential Inhibitors of CrDMB-GIcCer Transport from the Plasma Membrane to IntraceUular Membranes
Finally, we evaluated the effects of numerous reagents on the redistribution of CrDMB-GIcCer from the plasma membrane to intracellular membranes (Table II) . Cells were treated with various (a) inhibitors, (b) structural analogues of glucose or glucose transport inhibitors, (c) sphingolipid analogues, (d) protein modification reagents, (e) enzymes, (f) modifiers of cellular cholesterol, or (g) other reagents. With one exception, none of these reagents had an effect on 
Figure 6. Effect of temperature on the intraceUular redistribution
of Cs-DMB-GIcCer. Cells were incubated with Cs-DMB-GIcCer/ BSA for 30 rain at 2"C, washed, warmed for (,4) 2 h at 10*C, (B) 2 h at 19"C, or (C) 15 rain at 37"C before back exchange with DF-BSA. The samples were then photographed at green + red wavelengths. Bar, 10 t~m.
the intracellular labeling seen with Cs-DMB-GlcCer. Treatment of cells with a nonfluorescent GlcCer (Fig. 7 B) (but not GalCer; Fig. 7 C) analogue at a high concentration reduced labeling of the Golgi apparatus by Cs-DMB-GlcCer compared to control cells (Fig. 7 A) . (In this experiment, Cs-DMB-GIcCer was added before addition of the nortfluorescent GlcCer and GalCer analogues so that both control cells and cells treated with the nonfluorescent glycolipid analogues would contain the same amount of fluorescent lipid [see legend of Fig. 7] .) This result suggests that accumulation of Cs-DMB-GlcCer at the Golgi apparatus may be a saturable process.
Discussion
In this paper, we investigated the uptake and intracellular transport of a fluorescent analogue of glucosylceramide, Cs-DMB-GlcCer, and compared it to the behavior of three other fluorescent sphingolipid analogues (Cs-DMB-GalCer, Cs-DMB-LacCer, and Cs-DMB-SM), which also label the plasma membrane of human skin fibroblasts during incubations at low temperatures. We provide evidence that C~-DMB-GlcCer and Cs-DMB-GalCer are internalized by a combination of endocytosis and transbilayer movement ("flip flop") at the plasma membrane and endosomes. This latter process results in labeling of intracellular membranes and accumulation of the fluorescent lipids at the Golgi apparatus. In contrast, Cs-DMB-SM and Cs-DMB-LacCer appear to be internalized primarily by endocytosis, producing a punctate fluorescence pattern that is readily distinguished from that obtained with the Cs-DMB-GlcCer and Cs-DMB-GalCer analogues. and Cs-DMB-LacCer from the plasma membrane to intracellular membranes. These lipids are integrated into the plasma membrane bilayer during incubation at low temperature. During subsequent warming to 37°C, the fluorescent lipid is internalized into numerous fluorescent vesicles that are scattered throughout the cytoplasm (Fig. 2, A and B) , and, by analogy to previous studies with another sphingomyelin analogue, correspond to labeled endosomes (Koval and Pagano, 1990 ). This internalization process was ATP dependent (Fig. 4 ) and inhibited at low temperature (data not shown). Cs-DMB-SM could be almost completely removed from the cell surface after the low temperature labeling (see Table I ) by incubation with defatted BSA at low temperature (back exchange), suggesting that the fluorescent lipid was present in the outer leaflet of the plasma membrane bilayer. The presence of discrete "punctate dots" of fluorescence, rather than a more generalized labeling of many different intracellular membranes, suggests that Cs-DMB-SM and Cs-DMB-LacCer were restricted to the lumenal leaflet of endocytic vesicles (topologically equivalent to the outer leaflet of the plasma membrane bilayer) during internalization and, therefore, unable to equilibrate and label other cellular membranes. This idea is consistent with our finding that Cs-DMB-SM (as well as other C~-DMB-lipids) labeled many different intracellular membranes in perforated cells where the plasma membrane was disrupted and a barrier to transmembrane movement of lipids no longer existed (Fig. 3 B) .
Intracellular Transport of C~-DMB-SM and CrDMB-LacCer
In addition to labeling of endosomes, some labeling of the Golgi apparatus was also seen when Cs-DMB-SM or Cs-DMB-LacCer were used; (e.g., Fig. 2, A and B) . This most likely results from hydrolysis of these lipids at the plasma membrane and/or lysosomes and subsequent transport of the resulting fluorescent ceramide to the Golgi apparatus CKoval + + * Except for treatment with some of the sphingolipid analogues (see fourth footnote), cell cultures on glass coverslips were washed with HMEMB and preincubated (if indicated) with each reagent at the indicated concentration, temperature, and time. The cells were then washed, incubated with 10 ~M Cs-DMB-GIcCer/BSA for 30 rain at 2°C, washed, warmed to 37°C for 15-30 min, back exchanged, and examiAed for intracellular fluorescence. Where indicated, the reagents were also present throughout the experiment; i.e., during incubation with Cs-DMB-GIcCer, during warming and back exchange, and during the microscopic observation. Parallel control cultures showed intracellular fluorescence similar to that in Fig. 1 , C and D. ATP depletion was performed as described (Martin and Pasano, 1987) by pretreafing cells with 5 mM NaN3 and 50 mM 2-deoxyglucose in glucose-free HMEMB for 30 rain at 37°C, and performing all subsequent incubations and washes in glucose-free HMEMB containing these inhibitors. t +, Prominent labeling of the Goigi apparatus, e.g., as in Fig. 5 A; ±, reduced accumulation at the Golgi apparatus as in Fig. 5 B; -, minimal labeling of the Golgi apparatus as in Fig. 7 B. II Cell cultures on glass coversllps were washed with HMEMB, incubated with 2.5 ~tM C~-DMB-GIcCer/BSA for 30 rain at 2°C, washed, and warmed for 15 rain at 37°C in the presence of each sphingnlipid analogue/BSA complex (see Materials and Methods). The cells were then both back exchanged and observed in the presence of each sphingolipid analogue/BSA complex.
¶ N-ethylmaleimide treatment was followed by a 5-rain treatment on ice with 0.5 mM DTr in HMEMB and washing with HMEMB before incubation with Cs-DMBGIcCer/BSA. ** Fixative contained 3% paraformaldehyde and 0.02% glutsraldehyde in PBS. of CrDMB-GlcCer at the Golgi apparatus. Cells were incubated with 2.5/zM Cs-DMB-GIcCer/BSA for 30 rain at 2°C, washed, and warmed for 15 rain at 37°C in the presence of (,4) BSA alone, (B) 100/~M C6-GlcCer/BSA, or (C) 100/zM C6-GalCer/BSA. The samples were then back exchanged in the absence (A) or presence (B and C), of nonfluorescent C~-sphingolipid/BSA, and photographed at green + red wavelengths. Note the prominent labeling of the Golgi apparatus in (,4) and (C) relative to that in (B). Bar, 10 ~m.
and Pagano, 1990) , which has a high affinity for ceramide (Lipsky and Pagano, 1985; Pagano et al., 1989 Pagano et al., , 1991 Pagano, 1990b; Rosenwald and Pagano, 1993) .
IntraceUular Transport of CrDMB-GIcCer
Incubation of cells with CrDMB-GIcCer/BSA resulted in a markedly different pattern of intracellular fluorescence than that seen with Cs-DMB-SM and CrDMB-LacCer. When cells were treated with C~-DMB-GIcCer/BSA and subsequently warmed to 37°C, the fluorescent lipid redistributed into punctate dots of fluorescence throughout the cytoplasm and rapidly into other intracellular membranes; e.g., the nuclear envelope and Golgi apparatus. A working model for the intracellular transport of C~-DMB-GlcCer is given in Fig. 8 B and discussed below.
Transbilayer Movement of Cs-DMB-GIcCer at the Plasma Membrane and Subsequent Labeling of IntraceUular
Membranes. During low temperature incubation, CrDMBGlcCer labeled the plasma membrane. However, 25-30% of the Cs-DMB-GlcCer incorporated into the plasma membrane at low temperature was resistant to back exchange with defatted BSA (Table I) . One possible explanation for this observation is that a portion of the CrDMB-GIcCer was transported to the inner leaflet of the plasma membrane bilayer, where it became inaccessible to back exchange with defatted BSA (Fig. 8 B, step I) . Such a mechanism is the case for fluorescent analogues of phosphatidylethanolamine and phosphatidylserine, which label the plasma membrane of Chinese hamster fibroblasts and undergo transbilayer movement at low temperature (Martin and Pagano, 1987) . Alternatively, a portion of the Cs-DMB-GIcCer at the cell surface might interact with other cell surface constituents, reducing the size of the back-exchangeable pool of this lipid. Once present on the cytoplasmic leaflet of the plasma membrane, Cs-DMB-GIcCer could move by spontaneous or proteinmediated diffusion to label other intracellular membranes (Fig. 8 B, step II) . As discussed above for Cs-DMB-SM, such an explanation is consistent with our observations of Cs-DMB-GlcCer distribution in perforated cells after low temperature incubations.
Transbilayer Movement of CrDMB-GIcCer during Endocytosis and Subsequent Labeling of IntraceUular Membranes.
During warming to 37°C, some Cs-DMB-GIcCer also enters the cell by an endocytic route (Fig. 8 B, step III) .
Indeed, inhibition of endocytosis by ATP depletion eliminated the presence of punctate fluorescence in the cytoplasm, which most likely corresponds to endosomes, but otherwise had little effect on labeling of other intracellular membranes (compare Fig. 5, A 
and B, left panels).
It is likely that transbilayer movement of C~-DMB-GlcCer also occurs in endosomes (Fig. 8 B, step IV) , since in the time course experiment of Cs-DMB-GlcCer distribution (Fig. 1) , fluorescence was initially seen primarily in endosomes, while at later times, fluorescence was widely distributed in other intracellular membranes and reduced in vesiclelike structures. However, transport of Cs-DMB-GlcCer from endosomes to lysosomes was not required for labeling of the nuclear envelope, Golgi apparatus, and other intracellular membranes, since labeling of these membranes also occurred at 19°C (Fig. 6 B) , a temperature at which vesicular transport between endosomes and lysosomes is blocked (Dunn et al., 1980; Aulinskas et al., 1982) . Thick lines represent portions of the bilayer containing fluorescent lipid. (,4) Cs-DMB-SM and Cs-DMB-LacCer, initially present in the outer leaflet of the plasma membrane brayer, are restricted to the lumenal leaflet of endocytic vesicles and produce a punctate pattern of intracelinlar fluorescence during internalization. These lipids are also slowly transported to the lysosomes along the degradative pathway (see Koval and Pngano, 1990) . A portion of the fluorescent sphingomyelin is degraded by a neutral sphingomyelinase at the plasma membrane and an acidic sphingomyelinase in the lysosomes. The ceramide formed by this process subsequently stains the Golgi apparatus.
(B) Cs-DMB-GIcCer and Cs-DMB-GalCer, initially present in the outer leaflet of the plasma membrane brayer, undergo transbilayer movement to the cytosolic surfaces of the plasma membrane and endosomes. These fluorescent lipids are then able to label numerous intracellular membranes including the Golgi apparatus, where they accumulate. Roman numerals, steps of the internalization process discussed in text.
The process of Cs-DMB-GIcCer transport from the plasma membrane'and endosomes to label other intracellular membranes was inhibited at 10°C (Fig. 6) , but not by a wide variety of drugs, inhibitors, and enzymatic treatments (Table H) . Thus, it seems likely that the transbilayer movement of Cs-DMB-GlcCer at the plasma membrane and endosomes and subsequent labeling of intraceilular membranes by this lipid was not the result of a protein-mediated process, although we cannot completely exclude this possibility.
It is interesting to note that the intracellular distribution of Cs-DMB-GalCer was similar to that seen with Cs-DMBGlcCer, except that more vesicle-like structures and weaker labeling of the Golgi apparatus were seen when Cs-DMBGalCer was used (compare Fig. 2, C vs D) . This observation, along with our finding that Cs-DMB-GalCer is efficiently removed from the cell surface by back exchange ( Table I ), suggests that Cs-DMB-GalCer undergoes transbilayer movement at the plasma membrane and endosomes more slowly than Cs-DMB-GIcCer.
Accumulation of Cs-DMB-GIcCer at the Golgi Appara-
tus. The mechanism for accumulation of Cs-DMB-GlcCer at the Golgi apparatus (Fig. 8 B, step V) is unknown. Interestingly, incubation of ceils with a non-fluorescent analogue of GlcCer (but not GalCer) reduced the labeling of the Golgi apparatus by C5-DMB-GIcCer (compare Fig. 7 , A vs B), although it is not clear whether this analogue directly inhibited the accumulation of Cs-DMB-GIcCer at the Golgi apparatus, or reduced the labeling there because transport of Cs-DMB-GlcCer from the plasma membrane and endosomes to intracellular membranes was slowed. In addition, labeling of the Golgi apparatus by Cs-DMB-GIcCer was reduced in ATP-depleted cells (compare Fig. 5 , A vs B, right panels), suggesting that accumulation of the GlcCer analogue at this organelle might be an energy-dependent process. The accumulation of a fluorescent analogue of phosphatidylserine at the Golgi apparatus is also ATP-dependent (Kobayashi and Arakawa, 1991) .
One intriguing possibility for the a~umulalion of C5-DMBGlcCer at the Golgi apparatus is related to the synthesis of endogenous GlcCer. Previous studies have demonstrated that GlcCer synthase is enriched at the Golgi complex, and that synthesis of GlcCer occurs on the cytosolic surface of membrane vesicles derived from this organelle (Coste et al., 1985 (Coste et al., , 1986 Futerman and Pagano, 1991; Jeckel et al., 1992; Trinchera et al., 1991) . These findings imply that after its synthesis, GlcCer must undergo transbilayer movement to the lumenal surface to account for the known topology of higher order glycosphingolipids within the Golgi apparatus and plasma membrane. Thus, it is tempting to speculate that Cs-DMB-GlcCer accumulates at the Golgi apparatus because it uses the same molecular machinery present at the Golgi apparatus for transbilayer movement of newly synthesized endogenous GlcCer.
Sorting of Sphingolipids in the Endocytic Pathway
The intracellular transport of N- (N-[6-[(7-nitrobenz-2-oxa- 1,3-diazol-4-yl)amino] hexanoyl]) glucosyl sphingosine (C6-NBD-GIcCer) has been examined in several cell types and its internalization from the plasma membrane compared with the corresponding analogue of sphingomyelin, C6-NBD-SM (K_ok et al., 1989, 1991, 1992) . Evidence is presented that in the human colon adenocarcinoma cell line HT29, C6-NBD-GIcCer and C6-NBD-sphingosylphosphorylcholine are sorted during internalization along the endocytic pathway CKok et al., 1991); i.e., while C~-NBD-GlcCer is transported to the Golgi apparatus, C6-NBD-sphingosylphosphorylcholine moves predominantly to the lysosomes. Although the mechanism for the sorting of these sphingolipid analogues is unknown, it was suggested that these lipids separate from one another by sequestration into different membrane domains that enter different populations of endosomes . While the present study was carried out using different fluorescent analogues of GlcCer and sphingomyelin and a different cell type, it raises the possibility that these lipids may segregate from one another upon internalization from the plasma membrane because they use endocytic and nonendocytic uptake mechanisms to different extents.
